Skip to Navigation Skip to Search Skip to Content
Search All Centers

Stephan Stilgenbauer, MD

Associate Professor at the Department of Haematology, Oncology, Rheumatology and Infectious Diseases, University of Ulm

Dr. Stephan Stilgenbauer is Professor in the Department of Hematology, Oncology, Rheumatology and Infectious Diseases at the University of Ulm, Germany. He received his medical training at Ruprecht-Karls Universität Heidelberg Medical School, Germany with electives in Hamilton, Canada; Jerusalem, Israel; Bath, UK and Cambridge, UK. He went on to complete his final year at the Baylor College of Medicine and MD Anderson Cancer Center in Houston, Texas. His research is focused on the investigation of molecular factors in pathogenesis, and prognosis of CLL and other lymphomas as well as the development of novel treatment approaches for these diseases. Dr. Stilgenbauer has authored or co-authored numerous original articles, reviews and book chapters in journals such as the New England Journal of Medicine, Lancet, Nature, Nature Medicine, Journal of Clinical Oncology, Blood, Leukemia, Oncogene, and Haematologica. Dr. Stilgenbauer has received research support from AbbVie, Amgen, Boehringer-Ingelheim, Celgene, Genentech, Genzyme, Gilead, GSK, Janssen, Mundipharma, Novartis, Pharmacyclics, Hoffmann La-Roche and Sanofi.

 

 

Programs Featuring Stephan Stilgenbauer, MD (1)